{"id":"https://openalex.org/W3205944481","doi":"https://doi.org/10.1016/j.jns.2021.118388","title":"Relationship of pharmacokinetics and pharmacodynamics to apitegromab efficacy in patients with later-onset spinal muscular atrophy (Types 2 and 3 SMA): Results from the TOPAZ study","display_name":"Relationship of pharmacokinetics and pharmacodynamics to apitegromab efficacy in patients with later-onset spinal muscular atrophy (Types 2 and 3 SMA): Results from the TOPAZ study","publication_year":2021,"publication_date":"2021-10-01","ids":{"openalex":"https://openalex.org/W3205944481","doi":"https://doi.org/10.1016/j.jns.2021.118388","mag":"3205944481"},"language":"en","primary_location":{"id":"doi:10.1016/j.jns.2021.118388","doi":"https://doi.org/10.1016/j.jns.2021.118388","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jns.2021.118388","pdf_url":null,"source":{"id":"https://openalex.org/S169054600","display_name":"Journal of the Neurological Sciences","issn_l":"0022-510X","issn":["0022-510X","1878-5883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Neurological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023561602","display_name":"Thomas O. Crawford","orcid":"https://orcid.org/0000-0003-0916-2797","observed_orcids":["https://orcid.org/0000-0003-0916-2797"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Crawford","raw_affiliation_strings":["Johns Hopkins Medicine, Pediatrics, Baltimore, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Medicine, Pediatrics, Baltimore, United States of America","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073384262","display_name":"Amy Place","orcid":"https://orcid.org/0000-0003-4575-7632","observed_orcids":["https://orcid.org/0000-0003-4575-7632"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Place","raw_affiliation_strings":["Scholar Rock, Inc., Global Medical Affairs, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Global Medical Affairs, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Doreen Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doreen Barrett","raw_affiliation_strings":["Scholar Rock, Inc., Clinical Ops, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical Ops, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089488814","display_name":"Shaun M. Cote","orcid":"https://orcid.org/0000-0003-4596-9301","observed_orcids":["https://orcid.org/0000-0003-4596-9301"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaun Cote","raw_affiliation_strings":["Scholar Rock, Inc., Discovery/bioanalytics, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Discovery/bioanalytics, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000780851","display_name":"George G. Nomikos","orcid":"https://orcid.org/0000-0003-2846-1426","observed_orcids":["https://orcid.org/0000-0003-2846-1426"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Nomikos","raw_affiliation_strings":["Scholar Rock, Inc., Clinical Development, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical Development, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026872313","display_name":"Guochen Song","orcid":"https://orcid.org/0009-0009-9502-1093","observed_orcids":["https://orcid.org/0009-0009-9502-1093"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guochen Song","raw_affiliation_strings":["Scholar Rock, Inc., Clinical Development, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical Development, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087903486","display_name":"Sanela Bilic","orcid":"https://orcid.org/0009-0007-0181-7134","observed_orcids":["https://orcid.org/0009-0007-0181-7134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanela Bilic","raw_affiliation_strings":["Vanadro, Drug Development, Dallas county, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanadro, Drug Development, Dallas county, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089088185","display_name":"Ashish V. Kalra","orcid":"https://orcid.org/0000-0002-3608-7502","observed_orcids":["https://orcid.org/0000-0002-3608-7502"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish Kalra","raw_affiliation_strings":["Scholar Rock, Inc., Preclinical, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Preclinical, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037213636","display_name":"Mara Sadanowicz","orcid":"https://orcid.org/0009-0005-0322-1110","observed_orcids":["https://orcid.org/0009-0005-0322-1110"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mara Sadanowicz","raw_affiliation_strings":["Scholar Rock, Inc., Clinical, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082080191","display_name":"Janet O\u2019Neil","orcid":"https://orcid.org/0009-0000-9209-868X","observed_orcids":["https://orcid.org/0009-0000-9209-868X"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet O'Neil","raw_affiliation_strings":["Scholar Rock, Inc., Clinical, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050749798","display_name":"Ryan Iarrobino","orcid":"https://orcid.org/0009-0007-1280-5649","observed_orcids":["https://orcid.org/0009-0007-1280-5649"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Iarrobino","raw_affiliation_strings":["Scholar Rock, Inc., Clinical Operations, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical Operations, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054612368","display_name":"Nathalie L. Kertesz","orcid":"https://orcid.org/0000-0001-6955-5934","observed_orcids":["https://orcid.org/0000-0001-6955-5934"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie Kertesz","raw_affiliation_strings":["Scholar Rock, Inc., Global Medical Affairs, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Global Medical Affairs, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074295156","display_name":"Yung H. Chyung","orcid":"https://orcid.org/0009-0007-1548-8642","observed_orcids":["https://orcid.org/0009-0007-1548-8642"]},"institutions":[{"id":"https://openalex.org/I4210101493","display_name":"Scholar Rock (United States)","ror":"https://ror.org/01036m381","country_code":"US","type":"education","lineage":["https://openalex.org/I4210101493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yung Chyung","raw_affiliation_strings":["Scholar Rock, Inc., Clinical Development, Cambridge, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scholar Rock, Inc., Clinical Development, Cambridge, United States of America","institution_ids":["https://openalex.org/I4210101493"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"429","issue":null,"first_page":"118388","last_page":"118388"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spinal-muscular-atrophy-type-ii","display_name":"spinal muscular atrophy type 2","score":0.8399999737739563},{"id":"https://openalex.org/keywords/spinal-muscular-atrophy-type-3","display_name":"spinal muscular atrophy type 3","score":1.0},{"id":"https://openalex.org/keywords/myostatin-inhibition","display_name":"myostatin inhibition","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.8420000076293945},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8220000267028809},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8424442410469055},{"id":"https://openalex.org/C2777488582","wikidata":"https://www.wikidata.org/wiki/Q29630","display_name":"Myostatin","level":3,"score":0.8315388560295105},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6821752190589905},{"id":"https://openalex.org/C2777825866","wikidata":"https://www.wikidata.org/wiki/Q134985","display_name":"Topaz","level":2,"score":0.6451135873794556},{"id":"https://openalex.org/C2778558090","wikidata":"https://www.wikidata.org/wiki/Q580290","display_name":"Spinal muscular atrophy","level":3,"score":0.6232641935348511},{"id":"https://openalex.org/C161921814","wikidata":"https://www.wikidata.org/wiki/Q493743","display_name":"SMA*","level":2,"score":0.6062002182006836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5967402458190918},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46486741304397583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2998192310333252},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12703284621238708},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.10563305020332336},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C114614502","wikidata":"https://www.wikidata.org/wiki/Q76592","display_name":"Combinatorics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jns.2021.118388","doi":"https://doi.org/10.1016/j.jns.2021.118388","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jns.2021.118388","pdf_url":null,"source":{"id":"https://openalex.org/S169054600","display_name":"Journal of the Neurological Sciences","issn_l":"0022-510X","issn":["0022-510X","1878-5883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Neurological Sciences","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414801208","https://openalex.org/W3159808529","https://openalex.org/W4389366063","https://openalex.org/W4205532719","https://openalex.org/W4304182613","https://openalex.org/W3178972187","https://openalex.org/W4391669209","https://openalex.org/W7131299286","https://openalex.org/W4387310662","https://openalex.org/W7214734902"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-10-25T00:00:00"}